Patent
Medicine
Pharma
Health Care at Reasonable Cost: Protecting the Hatch-Waxman Act from Anticompetitive Gaming
This episode is audio from the Protecting the Hatch-Waxman Act from Anticompetitive Gaming panel from the Engelberg Center’s Hatch-Waxman at 40 and Beyond Symposium. It was recorded on September 26, 2024.
Anisha Dasgupta, Federal Trade Commission
Henry Hadad, Bristol-Myers Squibb
Steve Shadowen, Hilliard Shadowen LLP
Eric Stock, Gibson, Dunn & Crutcher LLP
Scott Hemphill, Engelberg Center on Innovation Law & Policy, NYU School of Law (moderator)